ATP-binding Cassette Transporter A1 (ABCA1) Functions as a Cholesterol Efflux Regulatory Protein*
暂无分享,去创建一个
[1] H. Rigneault,et al. Specific Docking of Apolipoprotein A-I at the Cell Surface Requires a Functional ABCA1 Transporter* , 2001, The Journal of Biological Chemistry.
[2] J. Wilcox,et al. Localization of Human ATP-Binding Cassette Transporter 1 (ABC1) in Normal and Atherosclerotic Tissues , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[3] Min Goo Lee,et al. Aberrant CFTR-dependent HCO-3 transport in mutations associated with cystic fibrosis , 2001, Nature.
[4] F. Quiocho,et al. Trapping the transition state of an ATP-binding cassette transporter: evidence for a concerted mechanism of maltose transport. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[5] R. Lawn,et al. ABCA1 Is the cAMP-inducible Apolipoprotein Receptor That Mediates Cholesterol Secretion from Macrophages* , 2000, The Journal of Biological Chemistry.
[6] C. Fielding,et al. A two-step mechanism for free cholesterol and phospholipid efflux from human vascular cells to apolipoprotein A-1. , 2000, Biochemistry.
[7] A. Tall,et al. Specific Binding of ApoA-I, Enhanced Cholesterol Efflux, and Altered Plasma Membrane Morphology in Cells Expressing ABC1* , 2000, The Journal of Biological Chemistry.
[8] J. Mcneish,et al. The Correlation of ATP-binding Cassette 1 mRNA Levels with Cholesterol Efflux from Various Cell Lines* , 2000, The Journal of Biological Chemistry.
[9] A. Horwitz,et al. Identification of cAMP analogue inducible genes in RAW264 macrophages. , 2000, Biochimica et biophysica acta.
[10] Yannick Hamon,et al. ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine. , 2000, Nature Cell Biology.
[11] T. Langmann,et al. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease , 1999, Nature Genetics.
[12] J. Piette,et al. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1 , 1999, Nature Genetics.
[13] C. Sensen,et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency , 1999, Nature Genetics.
[14] B. Masereel,et al. P-glycoprotein inhibition by glibenclamide and related compounds , 1999, Pflügers Archiv.
[15] B. Nilius,et al. Characterization of 19 disease-associated missense mutations in the regulatory domain of the cystic fibrosis transmembrane conductance regulator. , 1998, Human molecular genetics.
[16] S. Yokoyama,et al. Selective down-regulation by protein kinase C inhibitors of apolipoprotein-mediated cellular cholesterol efflux in macrophages. , 1997, Biochemistry.
[17] H. Brewer,et al. Decreased reverse cholesterol transport from Tangier disease fibroblasts. Acceptor specificity and effect of brefeldin on lipid efflux. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[18] Yong Ji,et al. Scavenger Receptor BI Promotes High Density Lipoprotein-mediated Cellular Cholesterol Efflux* , 1997, The Journal of Biological Chemistry.
[19] B. Verrier,et al. ABC1, an ATP Binding Cassette Transporter Required for Phagocytosis of Apoptotic Cells, Generates a Regulated Anion Flux after Expression in Xenopus laevis Oocytes* , 1997, The Journal of Biological Chemistry.
[20] Helen H. Hobbs,et al. Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor , 1996, Science.
[21] G. Francis,et al. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease. , 1995, The Journal of clinical investigation.
[22] P. Gros,et al. Phosphatidylcholine translocase: A physiological role for the mdr2 gene , 1994, Cell.
[23] P. Borst,et al. Homozygous disruption of the murine MDR2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease , 1993, Cell.
[24] M. Welsh,et al. Effect of ATP-sensitive K+ channel regulators on cystic fibrosis transmembrane conductance regulator chloride currents , 1992, The Journal of general physiology.
[25] M. Welsh,et al. Regulation by ATP and ADP of CFTR chloride channels that contain mutant nucleotide-binding domains. , 1992, Science.
[26] D. Papahadjopoulos,et al. Interactions of annexins with membrane phospholipids. , 1991, Biochemistry.
[27] S. Yokoyama,et al. Interaction of free apolipoproteins with macrophages. Formation of high density lipoprotein-like lipoproteins and reduction of cellular cholesterol. , 1991, The Journal of biological chemistry.
[28] J. Marsh,et al. Characterization of nascent high density lipoprotein subfractions from perfusates of rat liver. , 1989, Journal of lipid research.
[29] K. Uekama,et al. Cyclodextrin-induced hemolysis and shape changes of human erythrocytes in vitro. , 1982, Journal of pharmacobio-dynamics.
[30] D. Vaughan,et al. Reconstitution of lipoproteins. I. Lipid-protein interaction of high density apoproteins, purified apoA-I and apoA-II with dimyristoyl-lecithin and dimyristoyl-lecithin:cholesterol vesicles studied by isomeric spin-labelled lecithins. , 1980, Canadian journal of biochemistry.
[31] A. Tall,et al. Rat intestine secretes discoid high density lipoprotein. , 1978, The Journal of clinical investigation.
[32] R. Havel,et al. Discoidal bilayer structure of nascent high density lipoproteins from perfused rat liver. , 1976, The Journal of clinical investigation.
[33] A Kagan,et al. Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men. , 1976, The New England journal of medicine.
[34] F. Fahrenholz,et al. Cholesterol binds to synaptophysin and is required for biogenesis of synaptic vesicles , 1999, Nature Cell Biology.